HDAC inhibitors overcome first hurdle.
Garber
Ken
K
D002986:Clinical Trials as Topic / Q000639:trends; D017277:Drug Approval; D006331:Heart Diseases / Q000139:chemically induced*; D056572:Histone Deacetylase Inhibitors; D006801:Humans; D006877:Hydroxamic Acids / Q000009:adverse effects* / Q000627:therapeutic use*; D009369:Neoplasms / Q000188:drug therapy*; D018570:Risk Assessment; D014481:United States; D014486:United States Food and Drug Administration; D000077337:Vorinostat
D056572:Histone Deacetylase Inhibitors; D006877:Hydroxamic Acids; D000077337:Vorinostat